RSS feed

Publications (original articles or review articles) published in 2014 from OUS - Department of Cardiology Ullevaal (Div Med)

94 publications found

Abdelnoor M, Sandven I, Limalanathan S, Eritsland J (2014)
Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
Vasc Health Risk Manag, 10, 477-91
DOI 10.2147/VHRM.S67154, PubMed 25143742

Agewall S, Giannitsis E (2014)
"Troponin elevation in coronary ischemia and necrosis"
Curr Atheroscler Rep, 16 (3), 396
DOI 10.1007/s11883-013-0396-7, PubMed 24425063

Anker SD, Agewall S, Borggrefe M, Calvert M, Jaime Caro J, Cowie MR, Ford I, Paty JA, Riley JP, Swedberg K, Tavazzi L, Wiklund I, Kirchhof P (2014)
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
Eur Heart J, 35 (30), 2001-9
DOI 10.1093/eurheartj/ehu205, PubMed 24904027

Arauz A, Berge E, Sandercock P (2014)
Third International Stroke Trial 3: an update
Curr Opin Neurol, 27 (1), 8-12
DOI 10.1097/WCO.0000000000000045, PubMed 24241447

Atar D, Arheden H, Berdeaux A, Bonnet JL, Carlsson M, Clemmensen P, Cuvier V, Danchin N, Dubois-Randé JL, Engblom H, Erlinge D, Firat H, Halvorsen S, Hansen HS, Hauke W, Heiberg E, Koul S, Larsen AI, Le Corvoisier P, Nordrehaug JE, Paganelli F, Pruss RM, Rousseau H, Schaller S, Sonou G et al. (2014)
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results
Eur Heart J, 36 (2), 112-9
DOI 10.1093/eurheartj/ehu331, PubMed 25179768

Atar D, Bode C, Stuerzenbecher A, Verheugt FW (2014)
Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade
Fundam Clin Pharmacol, 28 (4), 353-63
DOI 10.1111/fcp.12063, PubMed 24494730

Bagai A, Tan M, Di Mario C, Halvorsen S, Cantor WJ, Le May MR, Fernandez-Aviles F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sánchez PL, Westerhout CM, Goodman SG, Yan AT (2014)
Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials
Am Heart J, 168 (5), 757-65
DOI 10.1016/j.ahj.2014.07.027, PubMed 25440805

Bang CN, Greve AM, Køber L, Rossebø AB, Ray S, Boman K, Nienaber CA, Devereux RB, Wachtell K (2014)
Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis
Int J Cardiol, 175 (3), 492-8
DOI 10.1016/j.ijcard.2014.06.013, PubMed 25012498

Beitland S, Platou ES, Sunde K (2014)
Drug-induced long QT syndrome and fatal arrhythmias in the intensive care unit
Acta Anaesthesiol Scand, 58 (3), 266-72
DOI 10.1111/aas.12257, PubMed 24397608

Berge HM, Gjesdal K, Andersen TE, Solberg EE, Steine K (2014)
Prevalence of abnormal ECGs in male soccer players decreases with the Seattle criteria, but is still high
Scand J Med Sci Sports, 25 (4), 501-8
DOI 10.1111/sms.12274, PubMed 24961617

Berge HM, Steine K, Andersen TE, Solberg EE, Gjesdal K (2014)
Visual or computer-based measurements: important for interpretation of athletes' ECG
Br J Sports Med, 48 (9), 761-7
DOI 10.1136/bjsports-2014-093412, PubMed 24563390

Byrkjeland R, Edvardsen E, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2014)
Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease
Diabetol Metab Syndr, 6 (1), 36
DOI 10.1186/1758-5996-6-36, PubMed 24612649

Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S (2014)
Health-related quality of life after myocardial infarction, does choice of method make a difference?
Scand Cardiovasc J, 48 (4), 216-22
DOI 10.3109/14017431.2014.923581, PubMed 24828790

Claussen PA, Abdelnoor M, Kvakkestad KM, Eritsland J, Halvorsen S (2014)
Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
Vasc Health Risk Manag, 10, 683-9
DOI 10.2147/VHRM.S72764, PubMed 25525366

Das D, Bakal JA, Westerhout CM, Hernandez AF, O'Connor CM, Atar D, McMurray JJ, Armstrong PW, Ezekowitz JA (2014)
The association between meteorological events and acute heart failure: new insights from ASCEND-HF
Int J Cardiol, 177 (3), 819-24
DOI 10.1016/j.ijcard.2014.11.066, PubMed 25465826

Ellingsrud C, Agewall S (2014)
[Morphine in the treatment of acute pulmonary oedema]
Tidsskr Nor Laegeforen, 134 (23-24), 2272-5
DOI 10.4045/tidsskr.14.0359, PubMed 25492336

Engeseth K, Hodnesdal C, Grundvold I, Liestøl K, Gjesdal K, Erikssen G, Kjeldsen SE, Erikssen JE, Bodegard J, Skretteberg PT (2014)
Heart rate reserve predicts cardiovascular death among physically unfit but otherwise healthy middle-aged men: a 35-year follow-up study
Eur J Prev Cardiol, 23 (1), 59-66
DOI 10.1177/2047487314553202, PubMed 25281482

Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A (2014)
Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension
Hypertension, 63 (5), 991-9
DOI 10.1161/HYPERTENSIONAHA.114.03246, PubMed 24591332

Finsen AV, Ueland T, Sjaastad I, Ranheim T, Ahmed MS, Dahl CP, Askevold ET, Aakhus S, Husberg C, Fiane AE, Lipp M, Gullestad L, Christensen G, Aukrust P, Yndestad A (2014)
The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling
PLoS One, 9 (11), e112172
DOI 10.1371/journal.pone.0112172, PubMed 25398010

Furenes EB, Opstad TB, Solheim S, Lunde K, Arnesen H, Seljeflot I (2014)
The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction
Mediators Inflamm, 2014, 385901
DOI 10.1155/2014/385901, PubMed 25294955

Gjerdalen GF, Hisdal J, Solberg EE, Andersen TE, Radunovic Z, Steine K (2014)
The Scandinavian athlete's heart; echocardiographic characteristics of male professional football players
Scand J Med Sci Sports, 24 (5), e372-80
DOI 10.1111/sms.12178, PubMed 24472028

Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K (2014)
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study
Int J Cardiol, 180, 122-8
DOI 10.1016/j.ijcard.2014.11.181, PubMed 25438232

Greve AM, Dalsgaard M, Bang CN, Egstrup K, Ray S, Boman K, Rossebø AB, Gohlke-Baerwolf C, Devereux RB, Køber L, Wachtell K (2014)
Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Stroke, 45 (7), 1939-46
DOI 10.1161/STROKEAHA.114.005296, PubMed 24903982

Greve AM, Dalsgaard M, Bang CN, Egstrup K, Rossebø AB, Boman K, Cramariuc D, Nienaber CA, Ray S, Gohlke-Baerwolf C, Okin PM, Devereux RB, Køber L, Wachtell K (2014)
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
Am J Cardiol, 114 (5), 751-6
DOI 10.1016/j.amjcard.2014.06.006, PubMed 25048345

Hall TS, Hallén J, Krucoff MW, Roe MT, Brennan DM, Agewall S, Atar D, Lincoff AM (2014)
Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Am Heart J, 169 (2), 257-265.e1
DOI 10.1016/j.ahj.2014.10.015, PubMed 25641535

Hall TS, Herrscher TE, Jarolim P, Fagerland MW, Jensen T, Agewall S, Atar D, Hallén J (2014)
Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea
Sleep Med, 15 (7), 762-8
DOI 10.1016/j.sleep.2014.03.008, PubMed 24841106

Hallén J, Atar D, Serebruany V (2014)
Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease
Am J Ther, 21 (2), 91-8
DOI 10.1097/MJT.0b013e3181b0a6ff, PubMed 19770797

Halvorsen S, Andreotti F, ten Berg JM, Cattaneo M, Coccheri S, Marchioli R, Morais J, Verheugt FW, De Caterina R (2014)
Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis
J Am Coll Cardiol, 64 (3), 319-27
DOI 10.1016/j.jacc.2014.03.049, PubMed 25034070

Halvorsen S, Atar D, Yang H, De Caterina R, Erol C, Garcia D, Granger CB, Hanna M, Held C, Husted S, Hylek EM, Jansky P, Lopes RD, Ruzyllo W, Thomas L, Wallentin L (2014)
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
Eur Heart J, 35 (28), 1864-72
DOI 10.1093/eurheartj/ehu046, PubMed 24561548

Hasvold LP, Bodegård J, Thuresson M, Stålhammar J, Hammar N, Sundström J, Russell D, Kjeldsen SE (2014)
Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients
J Hum Hypertens, 28 (11), 663-9
DOI 10.1038/jhh.2014.43, PubMed 25211055

Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl-Jørgensen K, Seljeflot I (2014)
Inflammation in childhood type 1 diabetes; influence of glycemic control
Atherosclerosis, 238 (1), 33-7
DOI 10.1016/j.atherosclerosis.2014.11.018, PubMed 25437887

Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T (2014)
Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction
Thromb Res, 135 (2), 329-33
DOI 10.1016/j.thromres.2014.11.028, PubMed 25496999

Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
Mediators Inflamm, 2014, 608414
DOI 10.1155/2014/608414, PubMed 24737925

Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L (2014)
Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy
Clin Chem, 61 (2), 368-78
DOI 10.1373/clinchem.2014.226936, PubMed 25451868

Holm T, Færestrand S, Larsen AI, Jønland KB, Gullestad L, Dickstein K, Köpp U, Sirnes PA, Tande P, Steen T, Kongsgård E (2014)
[Cardiac resynchronization therapy in heart failure--Norwegian guidelines]
Tidsskr Nor Laegeforen, 134 (10), E1-17
DOI 10.4045/tidsskr.13.0628, PubMed 24865746

Husebye T, Eritsland J, Arnesen H, Bjørnerheim R, Mangschau A, Seljeflot I, Andersen GØ (2014)
Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure
PLoS One, 9 (11), e112359
DOI 10.1371/journal.pone.0112359, PubMed 25390695

Haakonsen S, Sirnes PA, Gjesdal K (2014)
[A man in his eighties with recurrent syncope]
Tidsskr Nor Laegeforen, 134 (1), 52-5
DOI 10.4045/tidsskr.13.0241, PubMed 24429759

Jander N, Hochholzer W, Kaufmann BA, Bahlmann E, Gerdts E, Boman K, Chambers JB, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Wachtell K, Gohlke-Bärwolf C, Neumann FJ, Minners J (2014)
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF
Heart, 100 (24), 1946-53
DOI 10.1136/heartjnl-2014-305763, PubMed 25217488

Jortveit J, Govatsmark RE, Digre TA, Risøe C, Hole T, Mannsverk J, Slørdahl SA, Halvorsen S (2014)
Myocardial infarction in Norway in 2013
Tidsskr Nor Laegeforen, 134 (19), 1841-6
DOI 10.4045/tidsskr.14.0804, PubMed 25314984

Jusufovic M, Sandset EC, Bath PM, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2014)
Blood pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke
Stroke, 45 (11), 3440-2
DOI 10.1161/STROKEAHA.114.006433, PubMed 25256183

Kjeldsen S, Feldman RD, Lisheng L, Mourad JJ, Chiang CE, Zhang W, Wu Z, Li W, Williams B (2014)
Updated national and international hypertension guidelines: a review of current recommendations
Drugs, 74 (17), 2033-51
DOI 10.1007/s40265-014-0306-5, PubMed 25315030

Kjeldsen SE, Aksnes TA, Ruilope LM (2014)
Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring
Drugs R D, 14 (2), 31-43
DOI 10.1007/s40268-014-0049-5, PubMed 24842751

Kjeldsen SE, Fadl Elmula FE, Persu A, Jin Y, Staessen JA (2014)
Renal sympathetic denervation in the aftermath of Symplicity HTN-3
Blood Press, 23 (5), 256-61
DOI 10.3109/08037051.2014.953861, PubMed 25212427

Kjeldsen SE, Julius S, Dahlöf B, Weber MA (2014)
Physician (investigator) inertia in apparent treatment-resistant hypertension - insights from large randomized clinical trials. Lennart Hansson Memorial Lecture
Blood Press, 24 (1), 1-6
DOI 10.3109/08037051.2014.946787, PubMed 25162203

Kjeldsen SE, Sica D, Haller H, Cha G, Gil-Extremera B, Harvey P, Heyvaert F, Lewin AJ, Villa G, Mancia G, DISTINCT Investigators (2014)
Nifedipine plus candesartan combination increases blood pressure control regardless of race and improves the side effect profile: DISTINCT randomized trial results
J Hypertens, 32 (12), 2488-98; discussion 2498
DOI 10.1097/HJH.0000000000000331, PubMed 25144296

Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD, Beta-Blockers in Heart Failure Collaborative Group (2014)
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
Lancet, 384 (9961), 2235-43
DOI 10.1016/S0140-6736(14)61373-8, PubMed 25193873

Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO (2014)
Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
Chest, 146 (3), 727-734
DOI 10.1378/chest.13-2828, PubMed 25180723

Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Flem Jacobsen A, Granan LP, Halvorsen S, Guyatt G, Vandvik PO (2014)
Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the Antithrombotic Therapy and the Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Chest, 146 (3), 735-761
DOI 10.1378/chest.13-2993, PubMed 25180724

Limalanathan S, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P, Eritsland J (2014)
Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
J Am Heart Assoc, 3 (2), e000679
DOI 10.1161/JAHA.113.000679, PubMed 24760962

Lincoff AM, Roe M, Aylward P, Galla J, Rynkiewicz A, Guetta V, Zelizko M, Kleiman N, White H, McErlean E, Erlinge D, Laine M, Dos Santos Ferreira JM, Goodman S, Mehta S, Atar D, Suryapranata H, Jensen SE, Forster T, Fernandez-Ortiz A, Schoors D, Radke P, Belli G, Brennan D, Bell G et al. (2014)
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
Eur Heart J, 35 (37), 2516-23
DOI 10.1093/eurheartj/ehu177, PubMed 24796339

Lip GY, Laroche C, Boriani G, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Maggioni AP, Tavazzi L (2014)
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Europace, 17 (2), 194-206
DOI 10.1093/europace/euu201, PubMed 25149078

Lip GY, Windecker S, Huber K, Kirchhof P, Marin F, Ten Berg JM, Haeusler KG, Boriani G, Capodanno D, Gilard M, Zeymer U, Lane D, Document Reviewers, Storey RF, Bueno H, Collet JP, Fauchier L, Halvorsen S, Lettino M, Morais J, Mueller C, Potpara TS, Rasmussen LH, Rubboli A, Tamargo J et al. (2014)
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)
Eur Heart J, 35 (45), 3155-79
DOI 10.1093/eurheartj/ehu298, PubMed 25154388

Laake K, Myhre P, Nordby LM, Seljeflot I, Abdelnoor M, Smith P, Tveit A, Arnesen H, Solheim S (2014)
Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
BMC Geriatr, 14, 74
DOI 10.1186/1471-2318-14-74, PubMed 24928284

Madan M, Halvorsen S, Di Mario C, Tan M, Westerhout CM, Cantor WJ, Le May MR, Borgia F, Piscione F, Scheller B, Armstrong PW, Fernandez-Aviles F, Sanchez PL, Graham JJ, Yan AT, Goodman SG (2014)
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trials
JACC Cardiovasc Interv, 8 (1 Pt B), 166-174
DOI 10.1016/j.jcin.2014.09.005, PubMed 25616922

Majak P, Lunde IG, Hasic AK, Husebye T, Christensen G, Tønnessen T, Bjørnstad JL (2014)
Reduced visfatin levels in aortic stenosis increase after aortic valve replacement and may contribute to reverse left ventricular remodelling
J Cardiovasc Surg (Torino), 56 (3), 483-92
PubMed 24429804

Mellingsæter M, Wyller TB, Steen T (2014)
An elderly woman with unexplained falls and «tingling sensations in the head»
Tidsskr Nor Laegeforen, 134 (7), 717-20
DOI 10.4045/tidsskr.13.1288, PubMed 24721861

Melsom CB, Hussain RI, Ørstavik Ø, Aronsen JM, Sjaastad I, Skomedal T, Osnes JB, Levy FO, Krobert KA (2014)
Non-classical regulation of β1- and β 2-adrenoceptor-mediated inotropic responses in rat heart ventricle by the G protein Gi
Naunyn Schmiedebergs Arch Pharmacol, 387 (12), 1177-86
DOI 10.1007/s00210-014-1036-7, PubMed 25216690

Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR, Kjeldsen K, Jankowska EA, Atar D, Butler J, Fiuzat M, Zannad F, Pitt B, O'Connor CM (2014)
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
J Am Coll Cardiol, 64 (21), 2281-93
DOI 10.1016/j.jacc.2014.08.036, PubMed 25456761

Moltzau LR, Meier S, Aronsen JM, Afzal F, Sjaastad I, Skomedal T, Osnes JB, Levy FO, Qvigstad E (2014)
Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium
Naunyn Schmiedebergs Arch Pharmacol, 387 (5), 407-17
DOI 10.1007/s00210-013-0953-1, PubMed 24424715

Neldam S, Schumacher H, Kjeldsen SE, Neutel JM (2014)
Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension
Curr Med Res Opin, 30 (9), 1715-24
DOI 10.1185/03007995.2014.924912, PubMed 24834808

Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
Cytokine, 69 (1), 131-5
DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044

Omland T, Røsjø H, Giannitsis E, Agewall S (2014)
Troponins in heart failure
Clin Chim Acta, 443, 78-84
DOI 10.1016/j.cca.2014.08.016, PubMed 25151947

Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2014)
The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease
PLoS One, 9 (9), e106816
DOI 10.1371/journal.pone.0106816, PubMed 25191702

Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GØ, Levy FO, Skomedal T, Osnes JB, Qvigstad E (2014)
Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart
Br J Pharmacol, 171 (23), 5169-81
DOI 10.1111/bph.12647, PubMed 24547784

Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
J Acquir Immune Defic Syndr, 67 (4), 370-4
DOI 10.1097/QAI.0000000000000339, PubMed 25226210

Persu A, Azizi M, Jin Y, Volz S, Rosa J, Fadl Elmula FE, Pechere-Bertschi A, Burnier M, Mark PB, Elvan A, Renkin J, Sapoval M, Kahan T, Kjeldsen S, Staessen JA, European Network COordinating research on Renal Denervation (ENCOReD) consortium (2014)
Hyperresponders vs. nonresponder patients after renal denervation: do they differ?
J Hypertens, 32 (12), 2422-7; discussion 2427
DOI 10.1097/HJH.0000000000000347, PubMed 25375391

Persu A, Fadl Elmula FEM, Jin Y, Os I, Kjeldsen SE, Staessen JA (2014)
Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence
Eur Cardiol, 9 (2), 110-114
DOI 10.15420/ecr.2014.9.2.110, PubMed 30310496

Persu A, Jin Y, Baelen M, Vink E, Verloop WL, Schmidt B, Blicher MK, Severino F, Wuerzner G, Taylor A, Pechère-Bertschi A, Jokhaji F, Fadl Elmula FE, Rosa J, Czarnecka D, Ehret G, Kahan T, Renkin J, Widimsky J, Jacobs L, Spiering W, Burnier M, Mark PB, Menne J, Olsen MH et al. (2014)
Eligibility for renal denervation: experience at 11 European expert centers
Hypertension, 63 (6), 1319-25
DOI 10.1161/HYPERTENSIONAHA.114.03194, PubMed 24664290

Persu A, Jin Y, Fadl Elmula FE, Jacobs L, Renkin J, Kjeldsen S (2014)
Renal denervation after Symplicity HTN-3: an update
Curr Hypertens Rep, 16 (8), 460
DOI 10.1007/s11906-014-0460-x, PubMed 24913923

Radke PW, Halvorsen S, Jukema JW, Kolh P, Annemans L, Postma MJ, Ardissino D, Kristensen SD, Bassand JP, Collet JP, Morais J, Tuñón J, Halcox J (2014)
Networks for improving care in patients with acute coronary syndrome: A framework
Acute Card Care, 16 (2), 41-8
DOI 10.3109/17482941.2014.881502, PubMed 24654609

Sandset EC, Berge E, Kjeldsen SE, Julius S, Holzhauer B, Krarup LH, Hua TA (2014)
Heart rate as a predictor of stroke in high-risk, hypertensive patients with previous stroke or transient ischemic attack
J Stroke Cerebrovasc Dis, 23 (10), 2814-2818
DOI 10.1016/j.jstrokecerebrovasdis.2014.07.009, PubMed 25304725

Sanner H, Schwartz T, Flatø B, Vistnes M, Christensen G, Sjaastad I (2014)
Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage
PLoS One, 9 (3), e92171
DOI 10.1371/journal.pone.0092171, PubMed 24647150

Sanner H, Sjaastad I, Flatø B (2014)
Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool
Rheumatology (Oxford), 53 (9), 1578-85
DOI 10.1093/rheumatology/keu146, PubMed 24692575

Schwartz T, Sjaastad I, Flatø B, Vistnes M, Christensen G, Sanner H (2014)
In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction
Rheumatology (Oxford), 53 (12), 2214-22
DOI 10.1093/rheumatology/keu256, PubMed 24996906

Serebruany VL, Kipshidze N, Pershukov IV, Kuliczkowski W, Carnes J, Atar D (2014)
Fatal sepsis and systemic inflammatory response syndrome after off-label prasugrel: a case report
Am J Ther, 21 (6), e229-33
DOI 10.1097/MJT.0b013e31828fdb1c, PubMed 23665886

Serebruany VL, Pokov AN, Aradi D, Can M, DiNicolantonio J, Kipshidze N, Atar D (2014)
Effect of aliskiren and valsartan combination versus aliskiren monotherapy on hemostatic biomarkers in hypertensive diabetics: Aliskiren and Valsartan Impact in Diabetics pilot trial
Am J Ther, 21 (6), 482-90
DOI 10.1097/MJT.0b013e31826915ab, PubMed 23698186

Sinnaeve PR, Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Lambert Y, Danays T, Soulat L, Halvorsen S, Ortiz FR, Vandenberghe K, Regelin A, Bluhmki E, Bogaerts K, Van de Werf F, STREAM investigators (2014)
ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up
Circulation, 130 (14), 1139-45
DOI 10.1161/CIRCULATIONAHA.114.009570, PubMed 25161043

Skoglund PH, Svensson P, Asp J, Dahlöf B, Kjeldsen SE, Jamerson KA, Weber MA, Jia Y, Zappe DH, Östergren J, ACCOMPLISH investigators (2014)
Amlodipine+benazepril is superior to hydrochlorothiazide+benazepril irrespective of baseline pulse pressure: subanalysis of the ACCOMPLISH trial
J Clin Hypertens (Greenwich), 17 (2), 141-6
DOI 10.1111/jch.12460, PubMed 25529596

Stær-Jensen H, Sunde K, Olasveengen TM, Jacobsen D, Drægni T, Nakstad ER, Eritsland J, Andersen GØ (2014)
Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survivors of out-of-hospital cardiac arrest
Crit Care Med, 42 (11), 2401-8
DOI 10.1097/CCM.0000000000000515, PubMed 25072762

Sveen KA, Dahl-Jørgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR, Monnier VM, Hanssen KF (2014)
Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
J Diabetes Complications, 29 (3), 407-12
DOI 10.1016/j.jdiacomp.2014.12.011, PubMed 25600701

Svendsen M, Tonstad S, Heggen E, Pedersen TR, Seljeflot I, Bøhn SK, Bastani NE, Blomhoff R, Holme IM, Klemsdal TO (2014)
The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
Blood Press, 24 (1), 48-54
DOI 10.3109/08037051.2014.976979, PubMed 25483553

Sørensen H, Fadl Elmula FE, Kjeldsen SE, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
[Renal sympathetic denervation in treatment-resistant hypertension]
Tidsskr Nor Laegeforen, 134 (1), 32-6
DOI 10.4045/tidsskr.13.0276, PubMed 24429753

Ulimoen SR, Enger S, Norseth J, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2014)
Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation
Clin Cardiol, 37 (7), 422-7
DOI 10.1002/clc.22281, PubMed 24700386

van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P, Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ (2014)
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients
JACC Cardiovasc Imaging, 7 (9), 930-9
DOI 10.1016/j.jcmg.2014.05.010, PubMed 25212799

von Lueder TG, Atar D (2014)
Comorbidities and polypharmacy
Heart Fail Clin, 10 (2), 367-72
DOI 10.1016/j.hfc.2013.12.001, PubMed 24656112

von Lueder TG, Atar D, Krum H (2014)
Current role of neprilysin inhibitors in hypertension and heart failure
Pharmacol Ther, 144 (1), 41-9
DOI 10.1016/j.pharmthera.2014.05.002, PubMed 24836726

von Lueder TG, Wang BH, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H (2014)
Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy
Circ Heart Fail, 8 (1), 71-8
DOI 10.1161/CIRCHEARTFAILURE.114.001785, PubMed 25362207

Wardlaw JM, Murray V, Berge E, del Zoppo GJ (2014)
Thrombolysis for acute ischaemic stroke
Cochrane Database Syst Rev, 2014 (7), CD000213
DOI 10.1002/14651858.CD000213.pub3, PubMed 25072528

Wexels F, Dahl OE, Pripp AH, Seljeflot I, Borris LC, Haslund A, Gudmundsen TE, Lauritzen T, Lassen MR (2014)
Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism
Thromb Res, 134 (1), 68-71
DOI 10.1016/j.thromres.2014.04.011, PubMed 24824294

Willeit P, Thompson SG, Agewall S, Bergström G, Bickel H, Catapano AL, Chien KL, de Groot E, Empana JP, Etgen T, Franco OH, Iglseder B, Johnsen SH, Kavousi M, Lind L, Liu J, Mathiesen EB, Norata GD, Olsen MH, Papagianni A, Poppert H, Price JF, Sacco RL, Yanez DN, Zhao D et al. (2014)
Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration
Eur J Prev Cardiol, 23 (2), 194-205
DOI 10.1177/2047487314560664, PubMed 25416041

Wonnerth A, Katsaros KM, Krychtiuk KA, Speidl WS, Kaun C, Thaler K, Huber K, Wojta J, Maurer G, Seljeflot I, Arnesen H, Weiss TW (2014)
Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels
Metabolism, 63 (5), 647-53
DOI 10.1016/j.metabol.2014.02.005, PubMed 24629561

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z et al. (2014)
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence
J Hypertens, 32 (9), 1741-50
DOI 10.1097/HJH.0000000000000253, PubMed 24979302

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z et al. (2014)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial
J Hypertens, 32 (9), 1888-97
DOI 10.1097/HJH.0000000000000254, PubMed 24979303

Zannad F, Stough WG, Mahfoud F, Bakris GL, Kjeldsen SE, Kieval RS, Haller H, Yared N, De Ferrari GM, Piña IL, Stein K, Azizi M (2014)
Design considerations for clinical trials of autonomic modulation therapies targeting hypertension and heart failure
Hypertension, 65 (1), 5-15
DOI 10.1161/HYPERTENSIONAHA.114.04057, PubMed 25350982